|
| 37916303 | PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy. | BJU Int | 2024 |
| 35876044 | Impact of worsening surgically induced chronic kidney disease (CKD-S) in preoperative CKD-naïve patients on survival in renal cell carcinoma. | BJU Int | 2023 |
| 38024426 | A systematic review of robot-assisted partial nephrectomy outcomes for advanced indications: Large tumors (cT2-T3), solitary kidney, completely endophytic, hilar, recurrent, and multiple renal tumors. | Asian J Urol | 2023 |
| 37858374 | Outcomes of Patients With Advanced Renal Cell Carcinoma With Non-Clear Cell Histology Treated With Systemic Therapy. | Clin Genitourin Cancer | 2023 |
| 37558529 | Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis. | Clin Genitourin Cancer | 2023 |
| 37545849 | Selective Use of Neoadjuvant Targeted Therapy Is Associated with Greater Achievement of Partial Nephrectomy for High-complexity Renal Masses in a Solitary Kidney. | Eur Urol Open Sci | 2023 |
| 37880003 | Development of a novel score (RENSAFE) to determine probability of acute kidney injury and renal functional decline post surgery: A multicenter analysis. | Urol Oncol | 2023 |
| 37680219 | Oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma: a literature review. | Transl Androl Urol | 2023 |
| 37530659 | Partial versus radical nephrectomy for complex renal mass: multicenter comparative analysis of functional outcomes (Rosula collaborative group). | Minerva Urol Nephrol | 2023 |
| 37368355 | Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy. | Oncologist | 2023 |
| 37301663 | Impact of Variant Histology on Oncological Outcomes in Upper Tract Urothelial Carcinoma: Results From the ROBUUST Collaborative Group. | Clin Genitourin Cancer | 2023 |
| 36964236 | Gender-specific counselling of patients with upper tract urothelial carcinoma and Lynch syndrome. | World J Urol | 2023 |
| 37263828 | Assessing the Trade-off Between the Safety and Effectiveness of Off-clamp Robotic Partial Nephrectomy for Renal Masses with a High RENAL Score: A Propensity Score-matched Comparison of Perioperative and Functional Outcomes in a Multicenter Analysis. | Eur Urol Focus | 2023 |
| 37064092 | Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC). | Front Oncol | 2023 |
| 36856832 | Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. | World J Urol | 2023 |
| 36588000 | Age-Related Differences in Oncological Outcomes in Renal Cell Carcinoma: Impact of Functional Conservation as Measured by Postoperative eGFR. | Clin Genitourin Cancer | 2023 |
| 36879830 | Recent Advances in the Management of Localized and Locally Advanced Renal Cell Carcinoma: A Narrative Review. | Res Rep Urol | 2023 |
| 36874602 | The IRON Study: Investigation of Robot-assisted Versus Open Nephron-sparing Surgery. | Eur Urol Open Sci | 2023 |
| 36572219 | Renal Functional Outcomes in Patients With Angiomyolipomas: Surveillance vs Embolization vs Nephrectomy. | Urology | 2023 |
| 36372629 | Primary Cytoreductive Nephrectomy: Standing the Test of Time? | Eur Urol | 2023 |
| 36367175 | Percutaneous Ablation <i>vs</i> Robot-Assisted Partial Nephrectomy for Completely Endophytic Renal Masses: A Multicenter Trifecta Analysis with a Minimum 3-Year Follow-Up. | J Endourol | 2023 |
| 34308610 | Warm ischemia time length during on-clamp partial nephrectomy: does it really matter? | Minerva Urol Nephrol | 2022 |
| 35383431 | Neoadjuvant systemic therapy in patients undergoing nephroureterectomy for urothelial cancer: a multidisciplinary systematic review and critical analysis. | Minerva Urol Nephrol | 2022 |
| 35585014 | Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry. | Clin Genitourin Cancer | 2022 |
| 35410826 | Prognostic Significance of C-reactive Protein in Patients With Non-metastatic Papillary Renal Cell Carcinoma: Results from the INternational Marker Consortium for Renal Cancer (INMARC) Cohort. | Clin Genitourin Cancer | 2022 |
| 35377778 | Outcomes of Lymph Node Dissection in Nephroureterectomy in the Treatment of Upper Tract Urothelial Carcinoma: Analysis of the ROBUUST Registry. | J Urol | 2022 |
| 35730123 | Redo Robotic Partial Nephrectomy for Recurrent Renal Tumors: A Multi-Institutional Analysis. | J Endourol | 2022 |
| 35432672 | A case of percutaneous cryoablation complicated by subcapsular hemorrhage managed conservatively. | Radiol Case Rep | 2022 |
| 35572817 | Split Renal Function Is Fundamentally Important for Predicting Functional Recovery After Radical Nephrectomy. | Eur Urol Open Sci | 2022 |
| 36588010 | Corrigendum re "A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group)" [Eur Urol Focus 2022;8:173-81]. | Eur Urol Focus | 2022 |
| 36139591 | On-Clamp vs. Off-Clamp Robot-Assisted Partial Nephrectomy for cT2 Renal Tumors: Retrospective Propensity-Score-Matched Multicenter Outcome Analysis. | Cancers (Basel) | 2022 |
| 33781022 | Single-stage Xi® robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes. | Minerva Urol Nephrol | 2022 |
| 33549537 | A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group). | Eur Urol Focus | 2022 |
| 34995562 | Disparities in Cancer Specific and Overall Survival Outcomes in African Americans With Renal Cell Carcinoma: Analysis From the International Marker Consortium for Renal Cancer (INMARC). | Urology | 2022 |
| 35268334 | Is Hypertension Associated with Worse Renal Functional Outcomes after Minimally Invasive Partial Nephrectomy? Results from a Multi-Institutional Cohort. | J Clin Med | 2022 |
| 34991070 | Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2022 |
| 35019760 | Robotic <i>vs</i> Laparoscopic Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Multicenter Propensity-Score Matched Pair "tetrafecta" Analysis (ROBUUST Collaborative Group). | J Endourol | 2022 |
| 34806168 | Disparities and trends in the participation of minorities, women, and the elderly in breast, colorectal, lung, and prostate cancer clinical trials. | Cancer | 2022 |
| 31411997 | The Impact of Surgical Strategy in Robot-assisted Partial Nephrectomy: Is It Beneficial to Treat Anterior Tumours with Transperitoneal Access and Posterior Tumours with Retroperitoneal Access? | Eur Urol Oncol | 2021 |
| 33881931 | Risk Factors for Intravesical Recurrence after Minimally Invasive Nephroureterectomy for Upper Tract Urothelial Cancer (ROBUUST Collaboration). | J Urol | 2021 |
| 33773937 | Preoperative Elevation of C-Reactive Protein Is a Predictor for Adverse Oncologic Survival Outcomes for Renal Cell Carcinoma: Analysis from the International Marker Consortium Renal Cancer (INMARC). | Clin Genitourin Cancer | 2021 |
| 34580026 | Evaluation of the association of health care system access with kidney cancer surgical outcomes for hispanic and non-hispanic white patients. | Urol Oncol | 2021 |
| 34269808 | Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act. | JAMA Netw Open | 2021 |
| 34176762 | Prognostic Significance of Pancreatic Metastases in Patients With Advanced Renal Cell Carcinoma Treated With Systemic Therapy. | Clin Genitourin Cancer | 2021 |
| 34050813 | Retroperitoneal versus transepritoneal robot-assisted partial nephrectomy for postero-lateral renal masses: an international multicenter analysis. | World J Urol | 2021 |
| 33947640 | Corrigendum to 'Development of a Novel Risk Score to Select the Optimal Candidate for Cytoreductive Nephrectomy Among Patients with Metastatic Renal Cell Carcinoma. Results from a Multi-institutional Registry (REMARCC)' [European Urology Oncology 3 (2021) 256-263]. | Eur Urol Oncol | 2021 |
| 33249089 | Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis. | Eur Urol Focus | 2021 |
| 33218826 | Robot-assisted Radical Nephrectomy: A Systematic Review and Meta-analysis of Comparative Studies. | Eur Urol | 2021 |
| 33160847 | Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database. | Urol Oncol | 2021 |
| 33153954 | Robotic-assisted Partial Nephrectomy for "Very Small" (<2 cm) Renal Mass: Results of a Multicenter Contemporary Cohort. | Eur Urol Focus | 2021 |